In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bionomics Ltd.

www.bionomics.com.au

Latest From Bionomics Ltd.

Pipeline Watch: Phase III Progress With Bempedoic Acid, Lefamulin, And Ibrutinib Combo

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

 

Pipeline Watch Approvals

Just The Tonix: New York Biotech Has Breakthrough Drug For PTSD

Tonix Pharmaceuticals has won a breakthrough therapy designation this month for its post-traumatic stress disorder drug – the most advanced product in development specifically for the condition and potentially the first ever to market targeting PTSD as its lead indication.

Business Strategies Research & Development

Merck Invests In Bionomics

Neurology Australia

Interview: Six questions for Merck's Phil Kearney on Indian R&D

Dr Phil Kearney, MSD director (business development and licensing), India, South East Asia, Australia and New Zealand and ''scout'' behind Merck's Bionomics find, underscores that India, traditionally seen as a base for low FTE (full time equivalent) agreements, generic and follow-on innovations, has moved up the value chain.

Metabolic Disorders New Zealand
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • Bionomics Ltd.
  • Senior Management
  • Deborah Rathjen, PhD, CEO & Mng. Dir.
    Melanie Young, CFO
    Gabriel Kremmidiotis, PhD, VP, R&D
    Forrest H Fuller, PhD, VP, Bus. Dev.
  • Contact Info
  • Bionomics Ltd.
    Phone: (61) 8 8354 6100
    31 Dalgleish St.
    Thebarton, SA 5031
    Australia
Advertisement
Advertisement
UsernamePublicRestriction

Register